Viridian Therapeutics, Inc./DE Share-based Goods and Nonemployee Services Transaction, Stockholders' Equity
Viridian Therapeutics, Inc./DE (VRDN) reported Share-based Goods and Nonemployee Services Transaction, Stockholders' Equity of $330.00 thousand for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-13.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionStockholdersEquity · last filed 2015-11-13
- Viridian Therapeutics, Inc./DE share-based goods and nonemployee services transaction, stockholders' equity for the quarter ending 2015-09-30 was $0.00.
- Viridian Therapeutics, Inc./DE share-based goods and nonemployee services transaction, stockholders' equity for the quarter ending 2015-06-30 was $0.00.
- Viridian Therapeutics, Inc./DE share-based goods and nonemployee services transaction, stockholders' equity for the quarter ending 2015-03-31 was $330.00K.
| Period end | Share-based Goods and Nonemployee Services Transaction, Stockholders' Equity 3 month | Share-based Goods and Nonemployee Services Transaction, Stockholders' Equity 6 month | Share-based Goods and Nonemployee Services Transaction, Stockholders' Equity 9 month |
|---|---|---|---|
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $0.00 derived: sum of 2 quarters · filed 2015-11-13 | $330.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $330.00K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $330.00K 10-Q · filed 2015-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |